Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
pepvidalabs.com
Pepvida Labs holds a Disclosed Labs trust grade of F (59/100), computed independently from 27 lab Certificates of Analysis (as of July 2026). Their documented COA data is below our trust threshold — proceed with extra scrutiny. Scores come only from lab COAs; vendors can't pay to raise them.
What is Pepvida Labs's trust score?
Pepvida Labs scores 59/100 (Grade F) on Disclosed Labs, from 27 lab COAs (as of July 2026).
How is Pepvida Labs's trust score calculated?
Only from lab-issued Certificates of Analysis — average purity, safety-panel coverage, lab corroboration, and forgery signals. No vendor can pay to change it, and sponsorships never affect it.
Samples
Passed
Failed
Trust score updated: July 27, 2026 · 100% pass rate
Composite score based on 27 COAs attributed to this vendor.
Mean HPLC purity across published COAs
Per-peptide coverage of the safety panels each product form requires — identity, net-content, heavy-metals and residual-solvents for raw powders, plus endotoxin and sterility for injectables. Forms aren't penalized for panels they don't need.
Lab corroboration tier — confirmed via public verify portal (90), presumptive trusted lab (85), lab resolved but unverified (75), or no lab attribution (50)
| Date | Peptide | Test | Result | Purity | Lab | Notes |
|---|---|---|---|---|---|---|
| Jun 3, 2026 | Melanotan 2 | HPLC purity | PASS | 99.2% | Vanguard Laboratory | Lot PV-ML2-2606-01 · Report V260528-7 002 |
| Apr 6, 2026 | 5-Amino-1MQ | HPLC purity | PASS | 99.8% | Vanguard Laboratory | Lot PV-5AMIMQ-2604-01 · Report V260401-13 003 |
| Dec 24, 2025 | KPV | HPLC purity | PASS | 99.8% | Vanguard Laboratory |
See how Pepvida Labs's $/mg stacks up against every COA-verified vendor — updated daily.
Research profiles — side effects, mechanism, and lab-tested COA data for each peptide in this vendor's catalog.
Add a live, data-driven trust badge to your site or review. It updates automatically when new COAs are indexed — no account required.
Preview
Live badge (JavaScript)
<script async src="https://www.disclosedlabs.com/widget.js" data-vendor="pepvida-labs"></script>
Renders the dynamic grade badge. Best visual; the link is injected by script.
Static link (HTML) — best for SEO
<a href="https://www.disclosedlabs.com/vendors/pepvidalabs.com" rel="noopener" target="_blank" style="display:inline-flex;align-items:center;gap:8px;padding:8px 12px;border:1px solid #e2e8f0;border-radius:10px;background:#fff;color:#0f172a;text-decoration:none;font:600 13px/1.25 -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Helvetica,Arial,sans-serif"> COA Trust Score by Disclosed Labs — independent index of published COAs </a>
A plain, crawlable dofollow link in your page source. This is the version search engines credit.
Both point to Pepvida Labs's live profile at https://www.disclosedlabs.com/vendors/pepvidalabs.com.
Links back to Pepvida Labs's profile — a dofollow link (no sponsored or nofollow tagging). Score updates daily. Dark theme & options →
| 5-Amino-1MQ | vial | 50mg | $79.00 | $1.58 | In stock | 2026-07-27 | View → |
| AOD-9604 | vial | 5mg | $39.00 | $7.80 | In stock | 2026-07-27 | View → |
| BPC-157 | vial | 5mg | $30.00 | $6.00 | Sold out | 2026-07-27 | View → |
| BPC-157 | vial | 10mg | $64.00 | $6.40 | In stock | 2026-07-27 | View → |
| BPC-157 + TB-500 | blend | 10mg | $64.00 | $6.40 | In stock | 2026-07-27 | View → |
| Cagrilintide | vial | 5mg | $90.00 | $18.00 | Sold out | 2026-07-27 | View → |
| Cagrilintide | vial | 10mg | $170.00 | $17.00 | Sold out | 2026-07-27 | View → |
| CJC-1295 | vial | 5mg | $30.00$35.00 | $6.00 | In stock | 2026-07-27 | View → |
| Epitalon | vial | 10mg | $30.00 | $3.00 | In stock | 2026-07-27 | View → |
| GHK-Cu | vial | 100mg | $55.00 | $0.55 | In stock | 2026-07-27 | View → |
| GLOW Blend (GHK-Cu + BPC-157 + TB-500) | blend | 70mg | $95.00 | $1.36 | In stock | 2026-07-27 | View → |
| Glutathione | vial | 1200mg | $95.00 | $0.08 | In stock | 2026-07-27 | View → |
| Ipamorelin | vial | 10mg | $56.00 | $5.60 | In stock | 2026-07-27 | View → |
| KLOW Blend (GHK-Cu + BPC-157 + TB-500 + KPV) | blend | 80mg | $139.00 | $1.74 | In stock | 2026-07-27 | View → |
| KPV | vial | 16mg | $75.00 | $4.69 | In stock | 2026-07-27 | View → |
| MOTS-c | vial | 10mg | $49.00 | $4.90 | In stock | 2026-07-27 | View → |
| NAD+ | vial | 700mg | $79.00 | $0.11 | In stock | 2026-07-27 | View → |
| Retatrutide | vial | 10mg | $99.00 | $9.90 | In stock | 2026-07-27 | View → |
| Retatrutide | vial | 22mg | $195.00 | $8.86 | In stock | 2026-07-27 | View → |
| Retatrutide | vial | 30mg | $259.00 | $8.63 | In stock | 2026-07-27 | View → |
| Retatrutide | vial | 50mg | $469.00 | $9.38 | In stock | 2026-07-27 | View → |
| Retatrutide | vial | 60mg | $544.00 | $9.07 | Sold out | 2026-07-27 | View → |
| Retatrutide | vial | 100mg | $889.00 | $8.89 | In stock | 2026-07-27 | View → |
| Retatrutide | vial | 110mg | $899.00 | $8.17 | In stock | 2026-07-27 | View → |
| Retatrutide | vial | 220mg | $1749.00 | $7.95 | In stock | 2026-07-27 | View → |
| Selank | vial | 10mg | $35.00 | $3.50 | In stock | 2026-07-27 | View → |
| Semaglutide | vial | 5mg | $59.00 | $11.80 | Sold out | 2026-07-27 | View → |
| Semaglutide | vial | 10mg | $89.00 | $8.90 | In stock | 2026-07-27 | View → |
| Semaglutide | vial | 50mg | $419.00 | $8.38 | In stock | 2026-07-27 | View → |
| Semaglutide | vial | 100mg | $799.00 | $7.99 | In stock | 2026-07-27 | View → |
| Semax | vial | 10mg | $35.00 | $3.50 | In stock | 2026-07-27 | View → |
| Sermorelin | vial | 13mg | $79.00 | $6.08 | In stock | 2026-07-27 | View → |
| TB-500 | vial | 10mg | $64.00 | $6.40 | In stock | 2026-07-27 | View → |
| TB-500 | vial | 20mg | $130.00 | $6.50 | Sold out | 2026-07-27 | View → |
| Tesamorelin | vial | 10mg | $55.00 | $5.50 | In stock | 2026-07-27 | View → |
| Thymosin Alpha-1 | vial | 5mg | $42.00 | $8.40 | In stock | 2026-07-27 | View → |
| Tirzepatide | vial | 5mg | $65.00 | $13.00 | Sold out | 2026-07-27 | View → |
| Tirzepatide | vial | 12mg | $99.00 | $8.25 | In stock | 2026-07-27 | View → |
| Tirzepatide | vial | 32mg | $249.00 | $7.78 | In stock | 2026-07-27 | View → |
| Tirzepatide | vial | 66mg | $299.00 | $4.53 | Sold out | 2026-07-27 | View → |
| Tirzepatide | vial | 60mg | $469.00 | $7.82 | In stock | 2026-07-27 | View → |
| Tirzepatide | vial | 120mg | $889.00 | $7.41 | In stock | 2026-07-27 | View → |
| Tirzepatide | vial | 160mg | $1149.00 | $7.18 | In stock | 2026-07-27 | View → |
| Tirzepatide | vial | 320mg | $2199.00 | $6.87 | In stock | 2026-07-27 | View → |
Prices are scraped from pepvidalabs.com and may lag the live site. All prices are single-vial / pre-bulk list prices — bulk or bundle deals may be lower. $/mg is derived from the listed strength. “Updated” is when we last verified each listing.
We are continuously testing more products. Scores update with each new result.
Read our scoring methodology →Trust scores are computed from indexed Certificates of Analysis — vendor-published, and lab-confirmed where a lab copy verifies them — using a fixed, versioned methodology (v16). They are not based on independent blind-purchase testing, and no vendor can pay for placement or a higher score. How we score · How we make money
Inverse of CoaFlag count (lot collisions, hash collisions, etc.)
Composite of 27 COAs attributed to this vendor. Last recomputed 2026-07-27.
No phone number (-0.03), No physical address (-0.03), No business entity (-0.03)
Sources: RDAP/WHOIS for domain data, Twilio Lookup for phone classification, Google Places for address verification. Crawl runs weekly. Signals are independent of vendor-supplied data.
| Lot M112425Y · Report V251216-13 013 |
| Dec 24, 2025 | Sermorelin | HPLC purity | PASS | 99.09% | Vanguard Laboratory | Lot M112425Y · Report V251216-13 019 |
| Dec 16, 2025 | PT-141 | HPLC purity | PASS | 99.02% | Vanguard Laboratory | Lot M110125Y · Report V251216-13 016 |
| Nov 13, 2025 | CJC-1295 without DAC | HPLC purity | PASS | 99.446% | Janoshik Analytical | Lot 110525FF · Report 89181 |
| Jul 23, 2025 | Cagrilintide | HPLC purity | PASS | 99.8% | Vanguard Laboratory | Lot F0623255F · Report V2506269-9 009 |
| Jul 27, 2026 | GHK-Cu | HPLC purity | PASS | 99.8% | Vanguard Laboratory | Lot PV-GHKCu-2604-01 · Report V260401-13 002 |
| Jul 27, 2026 | NAD+ | HPLC purity | PASS | 98.57% | Vanguard Laboratory | Lot PV-NAD1K-2604-01 · Report V260423-16 001 |
| Jul 27, 2026 | Ipamorelin | HPLC purity | PASS | 99.02% | Vanguard Laboratory | Lot M110125Y · Report V251216-13 015 |
| Jul 27, 2026 | Semaglutide | HPLC purity | PASS | 99.7% | Vanguard Laboratory | Lot M112425Y · Report V251216-13 001 |
| Jul 27, 2026 | MOTS-C | HPLC purity | PASS | 99.01% | Vanguard Laboratory | Lot PV-MOT-2606-01 · Report V260528-7 001 |
| Jul 27, 2026 | Selank | HPLC purity | PASS | 99.8% | Vanguard Laboratory | Lot M112425Y · Report V251216-13 017 |
| Jul 27, 2026 | TB-500 | HPLC purity | PASS | 99.8% | Vanguard Laboratory | Lot M112425Y · Report V251216-13 020 |
| Jul 27, 2026 | BPC-157/TB-500 | HPLC purity | PASS | 99.8% | Vanguard Laboratory | Lot M112425Y · Report V251216-13 009 |
| Jul 27, 2026 | Epithalon | HPLC purity | PASS | 99.8% | Vanguard Laboratory | Lot M112425Y · Report V251216-13 011 |
| Jul 27, 2026 | Glutathione | HPLC purity | PASS | 99.8% | Vanguard Laboratory | Lot M112425Y · Report V251216-13 012 |
| Jul 27, 2026 | BPC-157 | HPLC purity | PASS | 99.8% | Vanguard Laboratory | Lot M112425Y · Report V251216-13 008 |
| Jul 27, 2026 | KLOW | HPLC purity | PASS | 99.5% | Vanguard Laboratory | Lot PV-KLOW-2604-01 · Report V260401-13 004 |
| Jul 27, 2026 | GLOW | HPLC purity | PASS | 99.5% | Vanguard Laboratory | Lot PV-GLOW-2604-01 · Report V260401-13 001 |
| Jul 27, 2026 | CJC-1295 no DAC/Ipamorelin | HPLC purity | PASS | 99.18% | Vanguard Laboratory | Lot M112425Y · Report V251216-13 010 |
| Jul 27, 2026 | AOD-9604 | HPLC purity | PASS | 99.8% | Vanguard Laboratory | Lot PV-AOD-2605-01 · Report V260515-13 001 |
| Jul 27, 2026 | Tirzepatide | HPLC purity | PASS | 99.8% | Vanguard Laboratory | Lot M112425Y · Report V251216-13 002 |
| Jul 27, 2026 | Retatrutide | HPLC purity | PASS | 99.8% | Vanguard Laboratory | Lot M112425Y · Report V251216-13 005 |
| Jul 27, 2026 | Semax | HPLC purity | PASS | 99% | Vanguard Laboratory | Lot M110125Y · Report V251216-13 018 |
| Jul 27, 2026 | Thymosin Alpha-1 | HPLC purity | PASS | 99.8% | Vanguard Laboratory | Lot M112425Y · Report V251216-13 022 |
| Jul 27, 2026 | Tesamorelin | HPLC purity | PASS | 99.8% | Vanguard Laboratory | Lot PV-TSM10-2604-01 · Report V260414-25 001 |
Disclosed Labs